Internal Medicine, Clinical Cardiatric Electrophysiology · New York, NY
NPI
1902064421
Since 2008
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
139 Centre St, Suite 307
New York, NY, 10013
Phone (212) 334-3507
Groups this clinician bills Medicare through
Medicare paid, 2024
$391K
6,315 services
Medicare patients, 2024
661
Average age 78
Drug cost, 2024
$11.1M
49,184 prescriptions
Company payments, 2025
$3,416
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David H Lau was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,522 times for 602 patients. In total David H Lau billed 6,315 services in 53 codes, and Medicare paid $391K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-20.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,522 | 602 | $13.86 | $21K |
| 99213 Office E&M - Established | Office | 1,330 | 554 | $73.19 | $97K |
| 93000 Electrocardiogram | Office | 943 | 595 | $11.33 | $11K |
| 93297 External Electrocardiographic Monitoring | Office | 552 | 68 | $47.77 | $26K |
| 93306 Echocardiography (TTE/TEE) | Office | 473 | 442 | $145.85 | $69K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 422 | 403 | $171.52 | $72K |
| 99212 Office E&M - Established | Office | 136 | 106 | $49.38 | $6,716 |
| 99454 E&M - Miscellaneous | Office | 94 | 11 | $39.05 | $3,671 |
| 99214 Office E&M - Established | Office | 84 | 71 | $109.73 | $9,217 |
| 99204 Office E&M - New | Office | 78 | 78 | $137.20 | $11K |
| 93925 Duplex Scan - Extremity Arteries | Office | 55 | 54 | $219.60 | $12K |
| 93970 Duplex Scan - Extremity Veins | Office | 54 | 54 | $165.09 | $8,915 |
| 93978 Duplex Scan - Extremity Arteries | Office | 47 | 45 | $128.00 | $6,016 |
| 93288 External Electrocardiographic Monitoring | Office | 46 | 31 | $46.43 | $2,136 |
| 93290 External Electrocardiographic Monitoring | Office | 31 | 22 | $17.67 | $548 |
By year: 2022 $698K for 6,882 services; 2023 $451K for 6,043 services; 2024 $391K for 6,315 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 125 | 18 | $4.20 | $525 |
Medicare prescription drug claims, 2024
In 2024, the drug David H Lau prescribed most often to Medicare patients was Metoprolol Succinate, with 4,659 prescriptions and refills. In total David H Lau wrote 49,184 Medicare prescriptions that cost $11.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 4,659 | 7,740 | 880 | $38K |
| Vascepa Icosapent Ethyl | 4,572 | 6,334 | 775 | $2.2M |
| Atorvastatin Calcium Generic | 2,822 | 4,820 | 572 | $18K |
| Xarelto Rivaroxaban | 2,571 | 3,564 | 419 | $2.0M |
| Eliquis Apixaban | 2,444 | 3,342 | 412 | $2.0M |
| Nitroglycerin Generic | 2,410 | 2,493 | 538 | $25K |
| Entresto Sacubitril/Valsartan | 1,960 | 2,415 | 294 | $1.6M |
| Ranolazine Er Ranolazine | 1,827 | 2,168 | 284 | $74K |
| Losartan Potassium Generic | 1,472 | 2,669 | 314 | $9,050 |
| Clopidogrel Clopidogrel Bisulfate | 1,311 | 2,340 | 292 | $8,506 |
| Amlodipine Besylate Generic | 1,272 | 2,193 | 271 | $6,139 |
| Diclofenac Epolamine Generic | 1,086 | 1,275 | 163 | $875K |
| Furosemide Generic | 852 | 1,058 | 219 | $2,252 |
| Montelukast Sodium Generic | 782 | 906 | 119 | $3,571 |
| Atenolol Generic | 637 | 961 | 114 | $3,281 |
Brand drugs: 16,654 claims; generic drugs: 32,486 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David H Lau $3,416 ($3,416 in general payments such as food, travel and fees) from 15 companies. The largest payer was Boston Scientific Corporation with $1,135.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 10 | $1,135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 21 | $448 |
| E.R. Squibb & Sons, L.L.C. BMY | 22 | $362 |
| Merck Sharp & Dohme LLC MRK | 11 | $243 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $205 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $194 |
| Cleerly, Inc. | 1 | $188 |
| Pfizer Inc. PFE | 7 | $164 |
| Abbott Laboratories ABT | 1 | $141 |
| Amgen Inc. AMGN | 5 | $122 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.